Mike Ward
Council of Regulators
World Health Organization Liaison to the DIA Board
Coordinator, Regulatory Systems Strengthening, Essential Medicines and Health Technologies, World Health Organization
Mike Ward is the Coordinator of the Regulatory System Strengthening Team of the Department of Essential Medicines and Health Technologies, Health Systems and Innovation Cluster, WHO Headquarters. Mr. Ward joined the WHO in 2015 as the Coordinator, Prequalification Team in the same Department.
Mr. Ward previously worked within Health Canada for close to 30 years as GMP specialist, drug evaluator and manager, international policy analyst and for the last 15 years, as Manager of the International Programs Division of the Therapeutic Products Directorate. Mr. Ward has extensive experience in the area of international regulatory cooperation, having served on numerous international harmonization steering committees. He was also responsible for helping launch the APEC Regulatory Harmonization Steering Committee, the International Generic Drug Regulators Pilot and the International Medical Device Regulators Forum. Mr. Ward started his professional career working in the areas of Quality Assurance and Production for Burroughs Wellcome, a former multi-national pharmaceutical firm based in the UK.
Mr. Ward received the Regulatory Affairs Professional Society Global Leadership Award in 2012.
Mr. Ward has a BSc in Physiology from McGill University.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China